ExodusPoint Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
ExodusPoint Capital Management's AMRX Position: Q3 2026 in Review
ExodusPoint Capital Management reduced its Amneal Pharmaceuticals (AMRX) stake by 9.6% in Q3 2026, selling an estimated $444K and leaving 232,171 shares worth $4.68M. The position accounts for 0.02% of the portfolio, ranked #585.
ExodusPoint Capital Management first reported a position in AMRX in Q2 2021 and has held it in 11 quarters since. The position peaked at $10.4M in Q4 2025. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- ExodusPoint Capital Management held 232,171 shares of Amneal Pharmaceuticals worth $4.68M as of Q3 2026.
- ExodusPoint Capital Management sold 24,672 Amneal Pharmaceuticals shares in Q3 2026, an estimated $444K.
- Amneal Pharmaceuticals made up 0.02% of ExodusPoint Capital Management's portfolio in Q3 2026, its #585 holding.
- ExodusPoint Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2021 and has held it in 11 quarters since.
- ExodusPoint Capital Management's Amneal Pharmaceuticals position peaked at $10.4M in Q4 2025.
- 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.